2022 GAPNA Pharmacology - 11.50 CH Included

Mar 25, 2022 ‐ Mar 26, 2022


This package includes 11.50 contact hours (which expire on 3/26/2024).

Members: $300.00
Standard: $350.00

Products

Pseudobulbar Affect (PBA) in a Long-Term Care Setting - Clinical Picture, Diagnosis, and Management (Sponsored by Avanir Pharmaceuticals)

Preview Available

Pseudobulbar Affect (PBA) in a Long-Term Care Setting - Clinical Picture, Diagnosis, and Management (Sponsored by Avanir Pharmaceuticals)

Mar 25, 2022 7:15am ‐ Mar 25, 2022 8:00am

Industry-Supported Presentation Theater

Breakfast will be provided. Attendees will be admitted on a first-come basis.

Supported by Avanir Pharmaceuticals

Speaker(s):
Free

Pharmacology Management of Infectious Diseases

Preview Available

Pharmacology Management of Infectious Diseases

Mar 25, 2022 8:00am ‐ Mar 25, 2022 9:00am

This session shares the latest information on pharmaceutical treatments for infectious diseases in the older adult population.

Continuing Education Instructions and Disclosure Information:

Contact hours available until 3/26/2024.

Requirements for Successful Completion:

Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.

Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):

Planning Committee Disclosures:
Pamela Cacchione, PhD, CRNP, BC, FGSA, FAAN, discloses that she receives royalties as editor-in-chief of Clinical Nursing Research an International Journal published by SAGE publishing. She also discloses that she serves as a consultant for Jonas Philanthropies.

There are no other Planning Committee disclosures to declare.

Speakers Disclosures:
Jason Gallagher, PharmD, BCPS, FCCP, FIDP, FIDSA, discloses that he serves as a consultant for Merck, Spero, Qpex, and Astellas. He also discloses that he receives other financial/material support via a grant from Merck.

There are no other speaker disclosures to declare.

Commercial Support:
No commercial support declared.

Accreditation Statement:
This educational activity is jointly provided by Anthony J. Jannetti, Inc. (AJJ) and the Gerontological Advanced Practice Nurses Association (GAPNA).

Anthony J Jannetti, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Anthony J. Jannetti, Inc. is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 5387.

Learning Outcome:
After completing this learning activity, the participant will be able to describe updated pharmaceutical treatments for infectious diseases in the older adult population.

Speaker(s):
  • Jason Gallagher, PharmD, BCPS, FCCP, FIDP, FIDSA, Clinical Professor and Clinical Pharmacy Specialist, Temple University School of Pharmacy and Hospital
Members: $30.00
Standard: $35.00

COVID Vaccines and Treatments

Preview Available

COVID Vaccines and Treatments

Mar 25, 2022 9:45am ‐ Mar 25, 2022 11:15am

This session reviews the latest research on vaccines and treatments for COVID-19 in the care of older adults.

Continuing Education Instructions and Disclosure Information:

Contact hours available until 3/26/2024.

Requirements for Successful Completion:

Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.

Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):

Planning Committee Disclosures:
Pamela Cacchione, PhD, CRNP, BC, FGSA, FAAN, discloses that she receives royalties as editor-in-chief of Clinical Nursing Research an International Journal published by SAGE publishing. She also discloses that she serves as a consultant for Jonas Philanthropies.

There are no other Planning Committee disclosures to declare.

Speakers Disclosures:
There are no speaker disclosures to declare.

Commercial Support:
No commercial support declared.

Accreditation Statement:
This educational activity is jointly provided by Anthony J. Jannetti, Inc. (AJJ) and the Gerontological Advanced Practice Nurses Association (GAPNA).

Anthony J Jannetti, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Anthony J. Jannetti, Inc. is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 5387.

Learning Outcome:
After completing this learning activity, the participant will be able to describe examples of latest research on vaccines and treatments for COVID-19 in the care of older adults.

Speaker(s):
  • Alfred Bacon III, MD, FACP, Clinical Assistant Professor, Jefferson Medical College
Members: $30.00
Standard: $35.00

Antiretroviral Therapy in Older Adults Living with HIV

Preview Available

Antiretroviral Therapy in Older Adults Living with HIV

Mar 25, 2022 11:20am ‐ Mar 25, 2022 12:20pm

This session shares the newest research in treatment approaches for the older adult with HIV.

Continuing Education Instructions and Disclosure Information:

Contact hours available until 3/26/2024.

Requirements for Successful Completion:

Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.

Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):

Planning Committee Disclosures:
Pamela Cacchione, PhD, CRNP, BC, FGSA, FAAN, discloses that she receives royalties as editor-in-chief of Clinical Nursing Research an International Journal published by SAGE publishing. She also discloses that she serves as a consultant for Jonas Philanthropies.

There are no other Planning Committee disclosures to declare.

Speakers Disclosures:
There are no speaker disclosures to declare.

Commercial Support:
No commercial support declared.

Accreditation Statement:
This educational activity is jointly provided by Anthony J. Jannetti, Inc. (AJJ) and the Gerontological Advanced Practice Nurses Association (GAPNA).

Anthony J Jannetti, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Anthony J. Jannetti, Inc. is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 5387.

Learning Outcome:
After completing this learning activity, the participant will be able to identify new research approaches in treatment approaches for the older adult with HIV.

Speaker(s):
  • Jeffrey Kwong, DNP, MPH, AGPCNP-BC, FAANP, FAAN, Professor, Rutgers University
Members: $30.00
Standard: $35.00

Discover the Impact of GEMTESA® (Vibegron) 75mg Tablets, An Effective OAB Treatment: A Fresh Look at OAB Management in Long-Term Care Settings (Sponsored by Urovant Sciences)

Preview Available

Discover the Impact of GEMTESA® (Vibegron) 75mg Tablets, An Effective OAB Treatment: A Fresh Look at OAB Management in Long-Term Care Settings (Sponsored by Urovant Sciences)

Mar 25, 2022 12:35pm ‐ Mar 25, 2022 1:20pm

Industry-Supported Presentation Theater

Lunch will be provided. Attendees will be admitted on a first-come basis.

Supported by Urovant Sciences.

This presentation theater discusses the clinical profile and prescribing information for GEMTESA® for the treatment of overactive bladder. The presentation also reviews challenges associated with overactive bladder in long-term care.

Speaker(s):
Free

Heart Failure

Preview Available

Heart Failure

Mar 25, 2022 1:20pm ‐ Mar 25, 2022 2:20pm

Expand your knowledge of the optimal medical management for heart failure in the geriatric population.

Continuing Education Instructions and Disclosure Information:

Contact hours available until 3/26/2024.

Requirements for Successful Completion:

Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.

Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):

Planning Committee Disclosures:
Pamela Cacchione, PhD, CRNP, BC, FGSA, FAAN, discloses that she receives royalties as editor-in-chief of Clinical Nursing Research an International Journal published by SAGE publishing. She also discloses that she serves as a consultant for Jonas Philanthropies.

There are no other Planning Committee disclosures to declare.

Speakers Disclosures:
There are no speaker disclosures to declare.

Commercial Support:
No commercial support declared.

Accreditation Statement:
This educational activity is jointly provided by Anthony J. Jannetti, Inc. (AJJ) and the Gerontological Advanced Practice Nurses Association (GAPNA).

Anthony J Jannetti, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Anthony J. Jannetti, Inc. is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 5387.

Learning Outcome:
After completing this learning activity, the participant will be able to discuss guideline-directed medical therapy for heart failure.

Speaker(s):
  • Margaret Shanks, MSN, CRNP, FNP-C, AGACNP-BC, AACC, Nurse Practitioner, Penn Presbyterian Medical Center
Members: $30.00
Standard: $35.00

Deprescribing in Older Adults

Preview Available

Deprescribing in Older Adults

Mar 25, 2022 2:50pm ‐ Mar 25, 2022 3:50pm

This session provides information on approaches to deprescribing, including common barriers and how to address them. Discussion includes use of several tools for deprescribing potentially inappropriate medications, as well as sample scripts for introducing deprescribing to patients and families.

Continuing Education Instructions and Disclosure Information:

Contact hours available until 3/26/2024.

Requirements for Successful Completion:

Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.

Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):

Planning Committee Disclosures:
Pamela Cacchione, PhD, CRNP, BC, FGSA, FAAN, discloses that she receives royalties as editor-in-chief of Clinical Nursing Research an International Journal published by SAGE publishing. She also discloses that she serves as a consultant for Jonas Philanthropies.

There are no other Planning Committee disclosures to declare.

Speakers Disclosures:
There are no speaker disclosures to declare.

Commercial Support:
No commercial support declared.

Accreditation Statement:
This educational activity is jointly provided by Anthony J. Jannetti, Inc. (AJJ) and the Gerontological Advanced Practice Nurses Association (GAPNA).

Anthony J Jannetti, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Anthony J. Jannetti, Inc. is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 5387.

Learning Outcome:
After completing this learning activity, the participant will be able to identify and discuss the rationale for deprescribing and describe one tool used for deprescribing.

Speaker(s):
  • Lori Martin-Plank, PhD, FNP-BC, NP-C, GNP-BC, Nurse Practitioner and Clinical Faculty, University of Arizona College of Nursing
Members: $30.00
Standard: $35.00

Diabetes Mellitus Management in the Older Adult

Preview Available

Diabetes Mellitus Management in the Older Adult

Mar 25, 2022 3:55pm ‐ Mar 25, 2022 5:25pm

This session addresses the current drug treatments for diabetes mellitus in the older adult population.

Continuing Education Instructions and Disclosure Information:

Contact hours available until 3/26/2024.

Requirements for Successful Completion:

Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.

Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):

Planning Committee Disclosures:

Pamela Cacchione, PhD, CRNP, BC, FGSA, FAAN, discloses that she receives royalties as editor-in-chief of Clinical Nursing Research an International Journal published by SAGE publishing. She also discloses that she serves as a consultant for Jonas Philanthropies.

There are no other Planning Committee disclosures to declare.

Speakers Disclosures:
There are no speaker disclosures to declare.

Commercial Support:
No commercial support declared.

Accreditation Statement:

This educational activity is jointly provided by Anthony J. Jannetti, Inc. (AJJ) and the Gerontological Advanced Practice Nurses Association (GAPNA).

Anthony J Jannetti, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Anthony J. Jannetti, Inc. is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 5387.

Learning Outcome:
After completing this learning activity, the participant will be able to discuss the current drug treatments for diabetes mellitus in the older adult population.

Speaker(s):
  • Amy M. Egras, PharmD, BCPS, BC-ADM, Associate Professor, Jefferson College of Pharmacy
Tags: diabetes
Members: $30.00
Standard: $35.00

New Drugs

Preview Available

New Drugs

Mar 26, 2022 8:00am ‐ Mar 26, 2022 9:00am

This session shares a potpourri of what's new in medications for the geriatric population.

Continuing Education Instructions and Disclosure Information:

Contact hours available until 3/26/2024.

Requirements for Successful Completion:

Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.

Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):

Planning Committee Disclosures:

Pamela Cacchione, PhD, CRNP, BC, FGSA, FAAN, discloses that she receives royalties as editor-in-chief of Clinical Nursing Research an International Journal published by SAGE publishing. She also discloses that she serves as a consultant for Jonas Philanthropies.

There are no other Planning Committee disclosures to declare.

Speakers Disclosures:
There are no speaker disclosures to declare.

Commercial Support:
No commercial support declared.

Accreditation Statement:
This educational activity is jointly provided by Anthony J. Jannetti, Inc. (AJJ) and the Gerontological Advanced Practice Nurses Association (GAPNA).

Anthony J Jannetti, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Anthony J. Jannetti, Inc. is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 5387.

Learning Outcome:
After completing this learning activity, the participant will be able to identify new medications of 2021 likely to be prescribed for the older adult population.

Speaker(s):
  • Laura Finn, BCGP, FASCP, RPh, Adjunct Associate Professor, Philadelphia College of Pharmacy
Members: $30.00
Standard: $35.00

Adjuvant Medications for Pain and Delirium Medication Toolbox

Preview Available

Adjuvant Medications for Pain and Delirium Medication Toolbox

Mar 26, 2022 9:05am ‐ Mar 26, 2022 10:05am

This session discusses the use of adjuvant medications for pain and typical psychotropic medications used for delirium for patients with life-limiting illness in acute and long-term care settings. Discussion includes an overview of the concept of pain, adjuvant pharmacology, and the risks and benefits of adjuvant medications. A delirium toolbox focuses on an overview on delirium, delirium assessment, and current evidence for the pharmacologic treatment of delirium.

Continuing Education Instructions and Disclosure Information:

Contact hours available until 3/26/2024.

Requirements for Successful Completion:

Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.

Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):

Planning Committee Disclosures:

Pamela Cacchione, PhD, CRNP, BC, FGSA, FAAN, discloses that she receives royalties as editor-in-chief of Clinical Nursing Research an International Journal published by SAGE publishing. She also discloses that she serves as a consultant for Jonas Philanthropies.

There are no other Planning Committee disclosures to declare.

Speakers Disclosures:
There are no speaker disclosures to declare.

Commercial Support:

No commercial support declared.

Accreditation Statement:
This educational activity is jointly provided by Anthony J. Jannetti, Inc. (AJJ) and the Gerontological Advanced Practice Nurses Association (GAPNA).

Anthony J Jannetti, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Anthony J. Jannetti, Inc. is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 5387.

Learning Outcome:

After completing this learning activity, the participant will be able to identify medications used for adjunctive pharmacologic management of pain and delirium.

Speaker(s):
  • Judith Barberio, PhD, APN, ANP-BC, GNP-BC, PMGT-BC, Clinical Associate Professor, Rutgers University
Members: $30.00
Standard: $35.00